Showing posts with label Eli Lilly; Milking Cancer Campaign; breast cancer; gemzar; alimta. Show all posts
Showing posts with label Eli Lilly; Milking Cancer Campaign; breast cancer; gemzar; alimta. Show all posts

Saturday, January 9, 2010

What's YOUR Breast Cancer IQ?

******
******
This last week I noted that women all over Facebook were "flying their colors," ostensibly to heighten awareness of breast cancer. What woman (or man) on Facebook is NOT aware, on some level, as to the existence & insidious prevalence of breast cancer? The REAL challenge is testing your breast cancer IQ.

How many are aware that despite the collective million steps taken and the commensurate millions of $$$$ raised that the treatment of breast cancer has changed little in the last 50 years?

How many of us question whether the assertion that deaths related to breast cancer are on the decline have more to do with creative accounting than medical successes?

Who stops to think about the hypocrisy and insult...and downright greed displayed by the tens of thousands of corporate dollar donations to breast cancer foundations while these same corporations concurrently report millions of dollars of profit from their cancer-causing products?

How much do we truly know about the breast cancer INDUSTRY? And how much of what we unwittingly do supports, if not perpetuates the industry, not the cure?

I challenge each of you, before you walk, run, pink, or fly your colors, to first be aware of whose cause you are truly benefiting.

Friday, October 16, 2009

PSA - Eli Lilly is Scrambling

******
******

Dear Tamera,


Last week I invited you to send your personal note to Eli Lilly thanking them for the cancer they are creating with rBGH.

Many people did just that, and it's having a huge impact. In response to our efforts, Eli Lilly's even begun covering its tracks, recently putting out an "independent panelist report" purporting the "safety" of rBGH - we have to keep the pressure on!

If it got by you last week, it's not too late now to get a card sent in your name to Eli Lilly. Just $10 bucks to BCA, and we'll send that card in your name.

If you sent a postcard to Eli Lilly last week, great and thank you. Click here to ask your friends and family to join you in sending a card to Eli Lilly.

Not only do we have a shot at stopping Eli Lilly from milking cancer… but your dollars will be used to keep us bad girls of breast cancer working hard. With an outfit like ours, every single dollar counts.

All the best, and thanks!

Tuesday, October 6, 2009

PSA - Send a "Thank You for the Cancer" Card to Eli Lilly

******
****** Eli Lilly is making money by increasing our risk of breast cancer, and then treating us once we develop the disease. It's unbelievable, unconscionable, and outrageous - and we're calling them out.

Here's how: We're sending them a thank you card.

What? No, we're not crazy! We need to get their attention and keep it, and the only way to do it is to be as outrageous as they are. So, we're sending them as many "Thanks for the cancer" cards as we possibly can. Will you send one too? It looks like this:

All you need to do to participate is make a $10 donation to Breast Cancer Action, and we'll send a card in your name to the pharmaceutical giant thanking them for the cancer they're causing with rBGH. You'll be letting Eli Lilly know not only that you're onto them - but that, by supporting us, you're fighting them too.

And that $10? Trust me. It goes a long way around here. Unlike most breast cancer organizations, we don't take money from the pharmaceutical industry, so we can use all the support we can get. Thank you!

Sincerely,

P.S. Learn more about the Milking Cancer campaign!


Breast Cancer Action | 55 New Montgomery St. #323 | San Francisco, CA 94105
Toll-free at 877-2STOPBC (278-6722) | www.bcaction.org | www.thinkbeforeyoupink.org

Wednesday, September 23, 2009

PSA - Stop "Milking Cancer" Campaign

******
******

Breast Cancer Action Challenges Pharma Giant's Marketing of the Artificial Hormone, Asks the Public to Demand Action

SAN FRANCISCO, Sept. 22 /PRNewswire-USNewswire/ -- Breast Cancer Action (BCA), known as the watchdog of the breast cancer movement, today announced the launch of their "Milking Cancer"

campaign challenging the pharmaceutical giant Eli Lilly to stop manufacturing rBGH. rBGH (recombinant bovine growth hormone, also known as rBST) has long been linked to cancer.

Eli Lilly is the sole manufacturer of rBGH which is sold worldwide under the name Posilac. The company also markets drugs to treat breast cancer and a drug to reduce the risk of breast cancer in women at high risk.

"Eli Lilly profits from cancer any way you look at it," said Barbara Brenner executive director of Breast Cancer Action. "It's the perfect profit cycle. When Eli Lilly milks cancer, it's great for the company, but bad for the public's health."

The artificial hormone rBGH has been banned in Japan, Australia, Canada and the European Union. Large corporations such as Wal-Mart and Starbucks no longer use milk from rBGH-treated cows in their store-brand products.

"There is strong evidence of a connection between rBGH and cancer, including breast cancer," according to Dr. Martin Donohoe, Adjunct Associate Professor, School of Community Health, Portland State University. "Many leading dairies and health care facilities have eliminated its use. Why should we take a chance with the public's health?"

BCA is launching the Milking Cancer campaign --featuring an on-line video and website, (www.milkingcancer.org) - to raise awareness and to encourage concerned consumers to contact Eli Lilly directly and tell them to stop manufacturing rBGH.

This project builds on BCA's Think Before You Pink(R)- a campaign raising critical questions about pink ribbon promotions and targeting "pinkwashers": companies that say they care about breast cancer, but make products that contribute to the incidence of the disease. Bolstered by the many successes of the campaign, including a 2008 effort that persuaded General Mills to discontinue the use of rBGH in pink-lidded Yoplait yogurt, Brenner urges people to believe they can effect change over Eli Lilly as well. "Ordinary people have extraordinary power to change corporate behavior," said Brenner. "People who care about public health can and will get Eli Lilly to stop milking cancer and end the manufacture of rBGH."

Breast Cancer Action is a non-profit education and advocacy organization that does not accept funding from pharmaceutical companies or any other organizations that profit from or contribute to the breast cancer epidemic.

Partners in the Milking Cancer Campaign are DES Action, Food and Water Watch, Institute for Responsible Technology, Massachusetts Breast Cancer Coalition, Our Bodies Ourselves, Physicians for Social Responsibility, and the Women's Community Cancer Project.


Sidebar: Looks like Eli Lilly is "milking" cancer on both ends...this entitles them to honorary enrollment in the ICBC, Inc.*

About Lilly Oncology, a Division of Eli Lilly and Company

For more than four decades, Lilly Oncology has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches. Our quest is to develop a broad portfolio of tailored therapies that accelerate the pace and progress of cancer care. To learn more about Lilly's commitment to cancer, please visit www.LillyOncology.com.

"Lilly continues to look for ways to improve the survival of people living with cancer and fill unmet needs in difficult to treat cancers," said Richard Gaynor, M.D., vice president, cancer research and global oncology platform leader for Lilly.

Source: Eli Lilly and Company

Major Products

Eli Lilly's top eight products have each generated net sales of more than $1 billion for 2008.

Eli Lilly 2007 product sales
Eli Lilly 2007 product sales

    • Gemzar (8.4% of 2008 sales) is a chemotherapy drug for lung cancer, pancreatic cancer, and breast cancer. Gemzar mimics a DNA building block, preventing DNA replication and tumor growth. Like many other chemotherapy drugs, this also stops the division of healthy cells, leading to severe side effects. Gemzar's patent is set to expire in November of 2010, however, as Lilly's method-of-use patent extension through 2013 was invalidated.
    • Alimta (5.7% of 2008 sales) is a lung and chest cancer drug.
    Excerpted from Forbes online report, dated 9/22/2009

    =================

    * ICBC, Inc. - Industrial Complex of Breast Cancer, Incorporated is a phrase coined by me to encompass the anomaly of the profit making industry that shrouds the study and treatment of breast cancer.